Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Long-lived memory immune cells continue to provide protection even after antibody levels drop.
Screening patients for autoantibodies against interferons could help predict which patients are more likely to become very sick.
Existing T cells may help account for the wide range COVID-19 symptoms.
Antibody analysis may provide guidance for developing vaccines and antibodies as treatments for COVID-19.
Both HIV and autoimmune clinicians reporting lower than expected incidence
Th1-Th2 “shift” rears its ugly head
“Young researchers such as myself…can provide a new perspective and contribute to the conversation for a cure,” says Chidera Ejikeme.
Over $12 million in grants has been awarded to the Wistar Institute to research the links between opioid receptors and immune activation.
Researchers compared the immune systems of South African women who started treatment at different points postinfection.
This apparently causes immediate immune reactions that effectively fuel its replication.
Scientists have created a two-headed protein that awakens latently HIV-infected immune cells and summons an immune response to kill them.
Researchers have found a so-called broadly neutralizing antibody that can recognize a key, shape-shifting portion of HIV
HIV uses a kind of “invisibility cloak” to hide in cells without alerting the body’s immune response—a finding that may lead...
An investigatory vaccine from the Baltimore-based Profectus BioSciences is both safe in humans and prompts an immune response to HIV proteins.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.